Listen " Can Sinaptica Slow Alzheimer’s Painful Decline; Heidi Dohse on patient-centered design "
Episode Synopsis
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi hears encouraging news from Ken Mariash, CEO of Sinaptica Therapeutics, a neuromodulation company developing a TMS system that may be able to slow the advance of Azheimer’s. Mariash paints a hopeful picture for people - and families - fearing this dreadful disease.
In our Future of MedTech Opportunities (FOMO) interview, DeviceTalks’ Emira Wininger talks with Heidi Dohse, founder and president of Tour de Heart. Dohse has used a pacemaker for nearly all of her life and brings important insights on the importance of patient design.
This episode is brought to you by Interpower Corp. Go to Interpower.com for more information.
Thank you for listening to this episode of the DeviceTalks Weekly Podcast.
***
Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
More episodes of the podcast DeviceTalks Podcast Network
How Enovis is accelerating orthopedic recovery with bone stimulation and patient-centered innovation
18/11/2025
Noah Medical’s clear vision for pulmonary bronchoscopy; FOMO: The true costs of MedTech tariffs
14/11/2025
Reimagining GI with AI: Olympus’ Blended Intelligence Approach to Burnout Relief & Patient Safety
11/11/2025
Medtronic’s Kowal describes an exciting future and new applications for cardiac pacing devices
07/11/2025
How Abbott is rethinking heart failure management through smarter monitoring and long-term support
27/10/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.